Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study

Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study

Abstract Background Cardiovascular diseases (CVD) is the leading cause of death among maintenance hemodialysis patients, with dyslipidemia being a prevalent complication. The paradoxical relationship between cardiovascular outcomes and established lipid risk markers, such as low-density lipoprotein...

Full description

Bibliographic Details
Main Authors: Lin Lin, Jie Teng, Yiqin Shi, Qiwen Xie, Bo Shen, Fangfang Xiang, Xuesen Cao, Xiaoqiang Ding, Xialian Xu, Zhen Zhang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Lipids in Health and Disease
Subjects:
Hemodialysis
Lipoprotein-associated phospholipase A2
Dyslipidemia
Cardiovascular disease
Online Access:https://doi.org/10.1186/s12944-023-01991-0

Similar Items

Similar Items